Fidelity’s feverish fee cuts a bid to cure market share woes
Over the past few weeks, Fidelity Investments has made strategic fee cuts and launched new products to ensure that its products are the cheapest in two categories in which the Vanguard Group Inc. has been eating their lunch for a decade.
“Vanguarditis,” the asset manager infection that leads to fee cuts and happier advisers, has worked its way into the heart of the Boston Behemoth.
Over the past few weeks, Fidelity Investments has made strategic fee cuts and launched new products to ensure that its products are the chea
Learn more about reprints and licensing for this article.
